Private Trust Co. NA Acquires 257 Shares of The Cooper Companies, Inc. $COO

Private Trust Co. NA lifted its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 25.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,278 shares of the medical device company’s stock after buying an additional 257 shares during the quarter. Private Trust Co. NA’s holdings in Cooper Companies were worth $91,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of the business. Nordea Investment Management AB lifted its position in shares of Cooper Companies by 7.9% during the second quarter. Nordea Investment Management AB now owns 16,976 shares of the medical device company’s stock worth $1,209,000 after acquiring an additional 1,243 shares in the last quarter. Praxis Investment Management Inc. lifted its holdings in Cooper Companies by 110.3% during the 2nd quarter. Praxis Investment Management Inc. now owns 7,950 shares of the medical device company’s stock worth $566,000 after purchasing an additional 4,170 shares in the last quarter. Generali Asset Management SPA SGR boosted its stake in Cooper Companies by 146.5% in the 2nd quarter. Generali Asset Management SPA SGR now owns 27,401 shares of the medical device company’s stock worth $1,950,000 after purchasing an additional 16,287 shares during the period. J.Safra Asset Management Corp grew its holdings in Cooper Companies by 204.8% during the 2nd quarter. J.Safra Asset Management Corp now owns 506 shares of the medical device company’s stock valued at $36,000 after buying an additional 340 shares in the last quarter. Finally, Boston Trust Walden Corp increased its position in shares of Cooper Companies by 1.9% during the second quarter. Boston Trust Walden Corp now owns 1,465,621 shares of the medical device company’s stock valued at $104,294,000 after buying an additional 27,644 shares during the period. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Price Performance

Shares of NASDAQ:COO opened at $74.45 on Thursday. The company’s fifty day moving average price is $69.65 and its 200-day moving average price is $73.22. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.12 and a quick ratio of 1.24. The firm has a market capitalization of $14.80 billion, a price-to-earnings ratio of 36.68, a PEG ratio of 1.97 and a beta of 1.02. The Cooper Companies, Inc. has a one year low of $61.78 and a one year high of $109.04.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.07 by $0.03. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The company had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.06 billion. During the same period in the previous year, the business earned $0.96 earnings per share. The firm’s quarterly revenue was up 5.7% compared to the same quarter last year. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. On average, equities research analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies declared that its board has approved a stock buyback plan on Wednesday, September 17th that allows the company to buyback $2.00 billion in outstanding shares. This buyback authorization allows the medical device company to reacquire up to 15.4% of its shares through open market purchases. Shares buyback plans are often an indication that the company’s board believes its shares are undervalued.

Insider Activity

In other news, COO Daniel G. Mcbride acquired 3,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 2nd. The shares were bought at an average cost of $65.04 per share, with a total value of $195,120.00. Following the acquisition, the chief operating officer owned 63,120 shares in the company, valued at approximately $4,105,324.80. This represents a 4.99% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Gerard H. Warner III bought 1,450 shares of the company’s stock in a transaction that occurred on Friday, September 5th. The stock was purchased at an average price of $69.23 per share, with a total value of $100,383.50. Following the transaction, the chief operating officer directly owned 18,319 shares in the company, valued at $1,268,224.37. The trade was a 8.60% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders purchased 17,975 shares of company stock worth $1,216,346. 1.98% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of equities analysts have recently commented on COO shares. Stifel Nicolaus cut their price objective on shares of Cooper Companies from $90.00 to $85.00 and set a “buy” rating for the company in a research report on Thursday, August 28th. Piper Sandler cut their price target on shares of Cooper Companies from $105.00 to $83.00 and set an “overweight” rating for the company in a report on Thursday, August 28th. BNP Paribas upgraded shares of Cooper Companies from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, July 22nd. Wells Fargo & Company lowered their price objective on Cooper Companies from $93.00 to $72.00 and set an “overweight” rating on the stock in a research report on Thursday, August 28th. Finally, Barclays initiated coverage on Cooper Companies in a research note on Monday, October 13th. They set an “overweight” rating and a $85.00 price objective for the company. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Cooper Companies presently has an average rating of “Moderate Buy” and an average target price of $84.77.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.